Plus Therapeutics Inc Registered Shs Forum: Community User: lockstoff

Steigendes Interesse, Ergebnisse werden erwartete, es wird mal wieder spannend. 🎡

next step upwards: https://finance.yahoo.com/news/plus-therapeutics-expands-cnside-assay-123000534.html

Es fängt an … die guten Nachrichten der letzten Zeit, dürfen sich jetzt bemerkbar machen.

nächste good-news: https://finance.yahoo.com/news/plus-therapeutics-announces-completion-u-123000454.html

Egal wie man es macht, abeni Du bist immer schneller 😉👌🏻

👀

Jetzt lässt mich mein Broker hoffentlich bis Mai in Ruhe mit ständigen RS-Mitteilungen...

PSTV Plus Therapeutics (PSTV) has an average analyst price target of approximately $8.00 from 4 to 6 analysts, with a high target of $21.00 and a low of $3.00. The consensus rating is a "Moderate Buy" or "Strong Buy," with a significant projected upside from the current price. Analysts at Ascendiant Capital and D. Boral Capital have issued some of the most recent ratings, with Ascendiant Capital setting a high target of $21.00 as of October 6, 2025. ·

$PSTV From PSTV website: While UnitedHealthcare is the first major insurer to step forward, Plus is in discussions with others, including Medicare. “The plan is to have all major payers on board,” Hedrick said. Bullish

Huiiii…😄👍🏼